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Abstract
The connection between social disadvantage and the presence of known diabetes and specific risk factors is well 
documented. This article summarises the results from the Robert Koch Institute examination surveys that were conducted 
between 1997 and 1999 as well as 2008 and 2011 to address social inequality – operationalised by level of education – 
with regard to prevalences of known and unknown diabetes, risk of diabetes and care of diabetes as well as their 
development over time. Both survey periods showed that the low education group has higher prevalences of known and 
unkown diabetes as well as a higher risk of developing diabetes within the next five years compared to the medium and 
high education group. Over time, prevalence tended to increase for known diabetes and to decrease for unknown diabetes 
for all education groups. For the 5-year diabetes risk, only the high education group showed a clear decrease over time. 
The chosen indicators of diabetes care indicated no clear differences between education groups and an improvement of 
diabetes care over time. For some indicators of care (foot examination, statins), improvements were only seen in the 
low education group. In conclusion, social inequalities in the prevalence of known and unknown diabetes as well as in 
diabetes risk remain in Germany; for the indicators of care, however, no clear education gradient is evident. Over time, 
inequality regarding the prevalence of diabetes has not increased further. However, with regard to diabetes risk, inequality 
has become slightly more evident. For individual care indicators, improvements are limited to specific education groups.
 DIABETES MELLITUS · EDUCATION · PREVALENCE · DIABETES RISK · DIABETES CARE 
1. Introduction
Diabetes mellitus is a metabolic disease with a disturbed 
regulation of blood glucose (blood sugar) [1]. The main risk 
factors of the disease’s most common form, type 2 dia-
betes, include unfavourable health-relevant behaviours 
such as lack of exercise, an unhealthy diet, and smoking, 
along with being overweight as a frequent consequence [2]. 
Unknown or inadequately treated diabetes leads to 
chronically elevated blood glucose concentrations. Blood 
vessels and the nervous system can be subsequently dam-
aged, resulting in diabetes-specific complications (such as 
renal dysfunction, eye disease, diabetic foot syndrome, and 
amputations of the lower limb) as well as cardiovascular 
diseases (such as heart attack and stroke). These severe 
diabetes-related diseases lead to a loss of health-related 
quality of life and life expectancy for affected individuals 
and place a high financial burden on the health system [3]. 




2.1  Study population
This article is based on data collected by two nationwide 
interview and examination surveys, the German National 
Health Interview and Examination Survey 1998 (GNHIES98, 
1997-1999) and the German Health Interview and Exami-
nation Survey for Adults (DEGS1, 2008-2011) conducted 
as part of the continuous health monitoring at the RKI 
(Info box 1). Figure 1 shows the study populations as they 
were defined for both survey periods and used for the esti-
mation of indicators of diabetes prevalence, diabetes risk 
and diabetes care.
2.2  Indicators
The definitions can be found for the indicators known dia-
betes and unknown diabetes in info box 2, for the indicator 
5-year risk of developing type 2 diabetes in info box 3, for 
indicators related to the quality of care for type 2 diabetes 
in the areas of achieving treatment goals and self-manage-
ment or medical care in info box 4 and info box 5, and for 
subjectively assessed health-related quality of life of type 2 
diabetes in info box 6.
The data used to calculate indicators stem from 
GNHIES98 and DEGS1 and were collected in the form of 
self-administered written questionnaires (including ques-
tions on smoking habits, physical activity, diet, health-re-
lated quality of life), physical examinations (including mea-
surements of body height, waist circumference, systolic 
and diastolic blood pressure), a computer-assisted medical 
interview (including questions on physician-diagnosed 
Due to these health impacts and the rising prevalence of 
diabetes – particularly of type 2 diabetes, which tends to 
become more frequent with increasing age – diabetes pre-
sents a major public health challenge in Germany and most 
other countries [2, 4].
Analyses of the temporal development of the presence 
of diabetes and its risk factors as well as the diabetes care 
situation are a decisive prerequisite to adapt or monitor 
prevention and care measures and to estimate the devel-
opment of diabetes-related health system expenditure. As 
socioeconomic factors are often related to health-relevant 
behaviour and its associated diseases, comparing popula-
tion groups and, where appropriate, developing target 
group- or setting-specific measures are important [5].
Such an analysis and provision of results on risks, pres-
ence and care of diabetes in Germany is the purpose of the 
national diabetes surveillance currently being developed 
at the Robert Koch Institute (RKI) [6]. The aim is to regu-
larly provide information on 40 defined indicators or indi-
cator groups [7]. This article considers the development 
over time of some key indicators of diabetes surveillance 
from the fields of diabetes risk, diabetes prevalence (fre-
quency of diabetes) and diabetes treatment for the overall 
German adult population as well as stratified by level of 
education and gender. It is based on the data of the pop-
ulation-representative health interview and examination 
surveys of the RKI.
Info box 1: 
Nationally representative interview and exam-
ination surveys for adults conducted by the 
Robert Koch Institute (cross-sectional surveys)
 German National Health Interview and 
Examination Survey 1998 (GNHIES98, 
1997-1999)
 German Health Interview and Examination 
Survey for Adults (DEGS1, 2008-2011) 
Objectives: Providing information on health status, 
health behaviour and health care of the population 
in Germany and analysis of trends over time 
Survey methods: Self-administered written ques-
tionnaire, physical examinations and tests, com-
puter-assisted medical interview, assessment of 
currently used medications, laboratory analyses 
of blood and urine samples
Target population: Adults aged 18 to 79 years with 
permanent residence in Germany
Sampling method: GNHIES98: Registry office sam-
ple; randomly selected individuals from 120 munic-
ipalities in Germany were invited to participate
DEGS1: Registry office sample; randomly selected 
individuals from 180 municipalities in Germany 
were invited to participate (120 original sample 
points of the GNHIES98 and 60 new sample 
points). 
Participants: GNHIES98: 7,124 adults
DEGS1: 7,987 adults (3,795 GNHIES98 revisiting 
participants, 4,192 first time participants)
Response rate: GNHIES98: 61%
DEGS1: 64% for GNHIES98 revisiting participants, 
42% for first time participants
More information can be found at Thefeld et al. 1999 
[8], Kamtsiuris et al. 2013 [9] and Scheidt-Nave et al. 
2012 [10] as well as at www.degs-studie.de/en
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(SF-36). However, a recommended standardisation proce-
dure was used to ensure comparability between the two 
versions [11]. The family history of diabetes was assessed 
exclusively in DEGS1. Detailed descriptions of the data col-
lection process have been published elsewhere [11-14].
All indicators are stratified by level of education and, 
additionally, gender. Level of education as an indicator of 
social inequality was defined via the CASMIN Index (Com-
parative Analysis of Social Mobility in Industrial Nations). 
This is based on the data provided by self-administered 
written questionnaires in GNHIES98 and DEGS1, which 
take both general and vocational training into account and 
diseases, family history of diabetes, self-monitoring of blood 
glucose, medical examinations of the eyes and feet), an 
assessment of currently used medications (including docu-
mentation of medications to treat diabetes (anti-diabetic 
drugs) and certain medications to treat lipid metabolism 
disorders (statins)) as well as laboratory analyses of blood 
samples (including determination of glycated haemoglo-
bin (HbA1c, a long-term blood sugar value), total and 
high-density lipoprotein cholesterol (HDL cholesterol)). In 
both surveys, indicators were obtained by similar methods. 
Only the health-related quality of life was assessed 
by different versions of the Short Form-36 Health Survey 
Info box 2: 
Indicator known diabetes: 
 Physician-diagnosed diabetes mellitus or 
 Taking anti-diabetic drugs (ATC-Code A10)
Indicator unknown diabetes:
 No known diabetes and
 Glycated haemoglobin (HbA1c) value ≥6.5%
Both indicators are given as a prevalence, i.e. a 
proportion (in %) of people with known or 
unknown diabetes mellitus (without differentiat-
ing between types of diabetes) in the population.
Source: Nationale Diabetes-Surveillance am Robert
Koch-Institut 2018 [7], Heidemann et al. 2016 [12]
ATC = Anatomical Therapeutic Chemical Classification System
Figure 1 
Study populations of the German National 
Health Interview and Examination Survey 1998 
and the German Health Interview and 
Examination Survey for Adults
Source: GNHIES98 (1997-1999), 
DEGS1 (2008-2011)
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prevalence of known diabetes as well as the prevalence of 
unknown diabetes (Info box 2). For the survey periods 1997 
to 1999 and 2008 to 2011, the prevalence of known dia-
betes was 5.6% and 7.2%, the prevalence of unknown dia-
betes was 3.8% and 2.0%, and the prevalence of total dia-
betes was 9.3% and 9.2%,respectively. Once differentiated 
by level of education, higher prevalence estimates of known 
and unknown diabetes, and therefore also of total diabetes, 
were found in the low compared to the medium and high 
education group in both survey periods. For the period 
between the two surveys, tendencies towards an increase 
in the prevalence of known diabetes and a decrease in the 
prevalence of unknown diabetes were evident in all educa-
tion groups. For overall diabetes, no significant changes in 
prevalence over time were observed [12] (Figure 2).
The sex-stratified analysis showed no significant differ-
ences in the prevalence of known diabetes between women 
(1997-1999: 5.7%, 2008-2011: 7.4%) and men (5.5%, 7.0%) 
[12]. Men, however, had a higher prevalence of unknown 
diabetes (1997-1999: 4.3%, 2008-2011: 2.9%) compared to 
women (3.2%, 1.2%) [12]. During the first survey period, 
this difference was particularly clear for the high education 
group, and during the second period, it was apparent for 
all education groups. Overall, however, for both survey peri-
ods, the pattern of higher prevalence estimates of known 
and unknown diabetes in the low education group com-
pared to the medium and high education groups has been 
observed for both genders. Over time, the prevalence of 
known diabetes increased and the prevalence of unknown 
diabetes decreased for both genders [12], whereby a further 
differentiation by education group was not always permit-
ting robust findings due to the low number of diabetes 
allow a categorisation into low, medium and high educa-
tion groups [15]. To depict indicators of care among per-
sons with type 2 diabetes, the medium and high education 
group were combined to avoid that the number of cases 
in the subgroups become too small.
2.3  Statistical analysis
All prevalence estimates and mean values as well as cor-
responding 95% confidence intervals have been calculated 
using weighting factors. Weighting factors correct for devi-
ations within the sample from the population structure as 
of 31 December 1997 for GNHIES98 and 31 December 2010 
for DEGS1 (regarding sex, age, region, German citizenship, 
size of municipality and education) and also consider the 
deviations in probability of participation in DEGS1 between 
participants who previously took part in GNHIES98 and 
DEGS1 first time participants [8-10]. For a comparison over 
time of the total samples of GNHIES98 and DEGS1 that 
was independent of the changes in the age pyramid, 
GNHIES98 data were age-standardised based on the pop-
ulation as of 31 December 2010. To take into account both 
weighting and the correlation of participants within one 
municipality, results were calculated using SAS 9.4 survey 
procedures. Differences with p-values <0.05 were consid-
ered as statistically significant.
3.  Results
3.1  Prevalence of known and unknown diabetes
To reflect the total diabetes burden in the population, the 
diabetes surveillance provides data for both indicators the 
Info box 3: 
Indicator 5-year risk of developing type 2 diabetes
The German Diabetes Risk Score (DRS) developed 
by the German Institute of Human Nutrition Pots-
dam-Rehbrücke calculates the absolute 5-year risk 
of developing type 2 diabetes (in %) for people who 
have so far not been diagnosed with diabetes. For 
example, a 5-year risk of 8% means that eight out 
of 100 people with the same DRS points will be 
diagnosed with type 2 diabetes over the course of 
the next five years.
   Diabetes Risk Score (DRS) points =
    5,1 x age (years)
 +7.6 x waist circumference (cm)
 –2.7 x body height (cm)
 +47 x physician-diagnosed hypertension
 –2 x physical activity (hours/week)
 +15 x former smoker <20 cigarettes/day
 +45 x former smoker ≥20 cigarettes/day
 +23 x smoker <20 cigarettes/day
 +77 x smoker ≥20 cigarettes/day
 –7 x whole grain consumption 
        (per 50g portion/day)
 – 5 x coffee consumption (per 150ml cup/day)
 + 55 x red meat consumption 
        (per 150g portion/day)
 + 56 x 1 parent with diabetes
 + 106 x both parents with diabetes 
 + 48 x brother or sister with diabetes
 
   5-year risk of developing type 2 diabetes = 
   1 – 0.99061 exp [(DRS points – 474.17096591)/100]
    This article indicates the average 5-year risk of devel-
oping diabetes for the population without known 
diabetes.
     Source: Nationale Diabetes-Surveillance am Robert
Koch-Institut 2018 [7], Paprott et al. 2017 [13]
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3.3  Type 2 diabetes care
Achieving treatment goals
The indicators for treatment goals of HbA1c-, non-HDL 
cholesterol and blood pressure were defined in the context 
of the diabetes surveillance based on treatment targets set 
out in the national guideline for the therapy of type 2 dia-
betes [16] or in the international recommendations on the 
treatment of high blood glucose levels [17, 18] and lipid 
metabolism disorders in people with type 2 diabetes [19, 
20] (Info box 4). By outlining the proportion of persons 
with type 2 diabetes who achieve the respective treatment 
goal, they provide intermediate outcome measures on the 
quality of care for type 2 diabetes.
For the indicator HbA1c treatment goal, no substantial 
differences between the low education group and the 
medium and high education group were evident for both 
survey periods. Over time, the proportion of people with 
type 2 diabetes that achieve the HbA1c goal increased 
almost equally in all education groups. The patterns and 
temporal developments were similar for both genders 
(Figure 4). The same applies for the indicators non-HDL 
cholesterol goal and blood pressure goal. However, only a 
small proportion of persons with type 2 diabetes reached 
the non-HDL cholesterol goal; only men from the medium 
or high education group achieved a more moderate result 
(nearly 50%) in the more recent survey period. For the pro-
portion of people with type 2 diabetes who reach the blood 
pressure goal, the overall increase over time was less pro-
nounced compared to the proportion of those who reached 
the HbA1c or non-HDL cholesterol goal. As a tendency, a 
slightly higher proportion of men in the medium and high 
cases for certain subgroups – this applies in particular to 
women with high education in the survey period 1997 to 
1999 (Figure 2).
3.2  5-year risk of developing type 2 diabetes
The indicator for the 5-year diabetes risk combines a set of 
established diabetes risk factors and helps to estimate how 
likely it is that a person will be diagnosed with type 2 dia-
betes within the next five years (Info box 3). For the survey 
periods 1997 to 1999 and 2008 to 2011, the average 5-year 
diabetes risk for the population was 1.5% and 1.1%, respec-
tively. For both survey periods, the risk of getting diagnosed 
with diabetes was significantly higher for the low education 
group compared to the medium and high education groups. 
Over time, a significant decrease in the 5-year diabetes risk 
was only observed in the high education group [13] (Figure 3).
Stratified by gender, the analysis of both survey periods 
indicated a higher 5-year diabetes risk for men (1997-1999: 
2.2%, 2008-2011: 1.5%) relative to women (1.1%, 0.8%). 
This difference between genders was observed across all 
education groups. In both genders, the pattern of a higher 
5-year diabetes risk for the low education group compared 
to the medium and high education groups was evident. 
While for women, only the high education group showed 
a decrease in the 5-year diabetes risk over time, this ten-
dency was visible across all education groups for men. 
However, it was also most pronounced in the high educa-
tion group among men (Figure 3).
Info box 4: 
Indicators of quality of care for type 2 diabetes – 
achieving treatment goals 
Treatment goal for HbA1c: 
  In the presence of diabetes-specific complica-
tions (diabetic renal dysfunction, diabetic eye 
disease, diabetic neuropathy, diabetic foot, dia-
betes-related amputation) or cardiovascular 
comorbidity (physician-diagnosed stroke, heart 
insufficiency, heart attack or other coronary 
heart diseases) and an age ≥45 years: HbA1c 
value <8.0%
  In the absence of diabetes- specific complica-
tions and cardiovascular comorbidity: 
 For an age ≥65 years: HbA1c value <7.5%
 For an age 45 to 64 years: HbA1c value 
<7.0%
Treatment goal for non-HDL cholesterol:
 Total cholesterol serum value minus HDL 
cholesterol serum value <130 mg/dl
Treatment goal for blood pressure: 
 Systolic blood pressure <140 mmHg and 
 Diastolic blood pressure <80 mmHg
Each indicator is given as proportion (in %) of 
persons with type 2 diabetes who achieve the 
respective treatment goal in relation to all persons 
with type 2 diabetes.
Source: Nationale Diabetes-Surveillance am Robert
Koch-Institut 2018 [7], Du et al. 2015 [14]
HbA1c = glycated haemoglobin (long-term blood sugar value)
non-HDL = non-high-density lipoprotein 
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5-year risk of developing type 2 diabetes over 
time for the 18- to 79-year-old population 
without known diabetes according 
 to gender and education level 
(GNHIES98 n=3,281 women, n=3,158 men; 
DEGS1 n=3,211 women, n=2,873 men)
Source: GNHIES98 (1997-1999), 
DEGS1 (2008 –2011), Paprott et al. 2017 [13]
Figure 2
Prevalence of known and unknown diabetes 
over time for the 18- to 79-year-old population 
according to gender and education level 
(GNHIES98 n=3,328 women, n=3,147 men; 
DEGS1 n=3,628 women, n=3,342 men)
Source: GNHIES98 (1997-1999), 
DEGS1 (2008-2011), Heidemann et al. 2016 [12]









DEGS1 (2008  – 2011) 
Low Medium
GNHIES98(1997 –1999)















GNHIES98(1997 –1999) DEGS1 (2008 –2011) 
Known diabetes Known diabetes
*
* Estimate is based on an overall low number of cases of known and unknown diabetes (n ≤ 5)
High Low Medium High Low Medium High
Education group
TotalWomen Men
Unknown diabetes Unknown diabetes
Journal of Health Monitoring
Journal of Health Monitoring 2019 4(2)
Social inequality and diabetes mellitus – developments over time among the adult population in Germany
17
FOCUS
recommendations for the prevention of cardiovascular dis-
eases in the presence of diabetes [20] (Info box 5). These 
indicators reflect results on the quality of diabetes care pro-
cesses through the respective proportion of type 2 diabetes 
patients with self-management or medical care.
For both survey periods, the indicator self-monitoring 
of blood glucose showed no significant differences between 
the low education group and the medium and high educa-
tion group. Over time, the proportion of type 2 diabetes 
patients who self-monitor their blood glucose level 
education group reached the blood pressure goal com-
pared to those in the low education group. 
Self-management and medical care
The diabetes surveillance system also considers further indi-
cators such as self-monitoring of blood glucose, medical eye 
and foot examinations as well as taking lipid-lowering 
statins based on national guidelines for the therapy of 
type 2 diabetes [16] and the prevention and treatment of 
retinal and foot complications [22, 23] as well as European 
Figure 4 
Comparison over time of the proportion of 
45- to 79-year-old persons with type 2 diabetes 
who reach the treatment goal for HbA1c, 
non-HDL cholesterol or blood pressure 
according to gender and education level 
(GNHIES98 n=161 women, n=156 men; 
DEGS1 n=226 women, n=297 men)
Source: GNHIES98 (1997-1999), 
DEGS1 (2008-2011), Du et al. [14, 21]
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twelve months tended to be lower compared to those 
with low education. And the proportion of men with higher 
levels of education who have had this examination increased 
to a smaller extend over time than for men with low edu-
cation. The proportion of persons with type 2 diabetes who 
have had their feet examined by a doctor during the last 
twelve months was lower in the higher education groups 
compared to the low education group for the period 2008 
to 2011, and this is related to the increase observed over 
time in the low education group only.
increased considerably, and this increase was similar across 
the education groups. These findings apply in principle to 
both genders, whereby the proportion of men in the two 
upper education groups who self-monitor their blood glu-
cose level is slightly higher in both survey periods com-
pared to the low education group (Figure 5). These obser-
vations cannot be fully transferred to the indicators for eye 
and foot examination. For eye examination in both survey 
waves, the proportion of women with higher levels of edu-
cation who have had this examination during the last 
Info box 5:  
Indicators of quality of care for type 2 diabetes – 
self-management and medical care
Self-monitoring of blood glucose:
 Self-monitoring of blood sugar levels
Eye examination: 
 Ophthalmologic examination of the ocular 
fundus during the last twelve months
Foot examination: 
 Medical examination of the feet during the 
last twelve months
Statin use:
 Taking the prescribed statin group medica-
tions (cholesterol synthesis-enzyme inhibi-
tors; ATC codes C10AA, C10BA)
Each indicator is given as proportion (in %) of 
persons with type 2 diabetes who achieve the 
respective care target in relation to all persons 
with type 2 diabetes.
Source: Nationale Diabetes-Surveillance am Robert
Koch-Institut 20188 [7], Du et al. 2015 [14]
ATC = Anatomical Therapeutic Chemical Classification System
Figure 5
Comparison over time of the proportion of 
 45- to 79-year-old type 2 diabetes patients 
with self-monitoring of blood glucose, 
eye examination and foot examinations 
according to gender and education level 
(GNHIES98 n=161 women, n=156 men; 
DEGS1 n=226 women, n=297 men)
Source: GNHIES98 (1997-1999), 
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time is apparent. This pattern applies to both genders 
(Figure 7).
4.  Conclusion
For public health research and health policy, analyses of 
trends in health inequality over time are a key factor to 
develop necessary target group focused prevention mea-
sures and evaluate existing prevention programmes.
As the results of this and other studies indicate, higher 
prevalence of diabetes in the low education group appears 
to be a persistent issue [12, 25-28]. The prevalence of both 
known and unknown diabetes remains twice as high in the 
low education group compared to the medium or high edu-
cation group [12]. The observed decline of unknown dia-
betes between the two survey periods, 1997 to 1999 and 
2008 to 2011, across all education groups and the simul-
taneous and roughly equivalent increase of known dia betes 
could indicate general improvements in the early detection 
of diabetes (secondary prevention). However, additional 
measures that aim at reducing the risk of developing dia-
betes (primary prevention) and focus primarily on the low 
education group seem necessary.
This fact is highlighted by the results for the 5-year risk 
of developing type 2 diabetes, which is twice as high for 
the low education group compared to the medium and 
high group and has clearly decreased only in the high edu-
cation group [13]. Studies of the individual behaviour-re-
lated risk factors of smoking and physical inactivity indicate 
a similar widening of inequality due to improvements exclu-
sively in the groups with high education or high profes-
sional status [29, 30]. In addition to prevention strategies 
For the period 1997 to 1999, a higher proportion of 
type 2 diabetes patients with higher levels of education 
took statins compared to those with low levels of educa-
tion, whereas for the period 2008 to 2011, the proportion 
of those taking statins tended to be higher in the low edu-
cation group. This result is due to a greater increase in the 
use of statins in the low education group compared to the 
higher education groups. These observations apply to both 
genders (Figure 6).
Health-related quality of life
In the diabetes surveillance, subjective assessments are 
also considered as relevant care indicators. These include 
self-perceived health-related quality of life, which is obtained 
by summing up the scales for the physical and mental 
dimensions of quality of life (Info box 6). In addition to 
objectively measureable care indicators (such as the treat-
ment goals mentioned above), self-perceived quality of life 
plays an important role for health and well-being and is 
therefore anchored as a general therapy objective in the 
national guideline for the therapy of typ 2 diabetes (‘main-
taining or regaining quality of life’) [16].
Regarding the physical dimension of health-related qual-
ity of life for type 2 diabetes patients, the period 1997 to 
1999 showed a similar – and the period 2008 to 2011 a 
slightly more positive – self-assessment in the higher edu-
cation groups compared to the low education group. This 
can be traced back to a marginally improved self-assess-
ment over time in the higher education groups. Regarding 
the self-assessed mental dimension of health-related qual-
ity of life, no differences between education groups were 
present in either survey period and a slight decline over 
Info box 6: 
Health-related quality of life of people with type 2 
diabetes 
Based on 36 questions (Short Form-36 Health Sur-
vey questionnaire, SF-36) and the scales devel-
oped from these on eight dimensions of health, 
two sum scales are calculated:
Physical dimension:
 Physical sum scale as the sum of the eight 
scales, whereby the highest weighting is given 
to the scales for physical functioning, physical 
role functioning, bodily pain and general 
health perception.
Mental dimension:
 Mental sum scale as the sum of the eight 
scales, whereby the highest weighting is giv-
en to the scales for vitality, social functioning, 
emotional role functioning and mental 
health.
Both dimensions of health-related quality of life 
can potentially achieve values between 0 and 100 
and have been transformed for a comparison 
between GNHIES98 (SF-36V1) and DEGS1 
(SF-36V2) into a sample mean of 50 and a stan-
dard deviation of 10. This article compares the 
mean values for different groups of people with 
type 2 diabetes, whereby a higher mean value rep-
resents a higher health-related quality of life.
Source: Nationale Diabetes-Surveillance am Robert
Koch-Institut 2018 [7], Ellert et al. 2013 [11]
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that aim to promote healthy lifestyles (behavioural preven-
tion), such as those already anchored in the national health 
target for type 2 diabetes [31], more emphasis needs to be 
put on the development of living environments and frame-
works that promote healthy living (structural prevention) 
and reach all education groups.
With regard to the diabetes care situation, a positive 
development has been that improvements over time have 
been achieved in several areas with no clearly visible dif-
ferences between education groups. Improvements are not 
only reflected for several indicators (HbA1c, non-HDL 
choles terol and blood pressure treatment goals, blood glu-
cose self-monitoring and eye examination) across different 
education groups in this study on the basis of RKI survey 
Figure 6
Comparison over time of the proportion of 
45- to 79-year-old persons with type 2 diabetes 
who take statins according to gender 
and education level 
(GNHIES98 n=161 women, n=156 men; 
DEGS1 n=226 women, n=297 men)
Source: GNHIES98 (1997-1999), 
DEGS1 (2008-2011), Du et al. [14, 21]
Figure 7
Comparison over time of mean values of sum 
scales for the physical and mental dimensions 
of health-related quality of life in 45- to 79-year-
old persons with type 2 diabetes 
according to gender and education level 
(GNHIES98 n=161 women, n=156 men; 
DEGS1 n=226 women, n=297 men) 
Source: GNHIES98 (1997-1999), 
DEGS1 (2008-2011), Schmidt et al. [24]
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guideline for the therapy of type 2 diabetes on specific dia-
betes complications, which encourage diabetes patients 
to play an active role in their treatment [38] as well as the 
DMP implementation for type 2 and type 1 diabetes [39]. 
Analysis of DMP data shows that a continuous DMP par-
ticipation increases the chance for patients to achieve 
defined targets for diabetes quality of care [40].
Nonetheless, the currently available study results on 
care of people with type 2 diabetes all highlight the consid-
erable potential for improvement in the prevention of sec-
ondary and concomitant diseases (tertiary prevention). In 
the present study, for example, the proportions of persons 
with type 2 diabetes who achieved the non-HDL cholesterol 
treatment goal or took statins were below 50% across all 
education groups in the period 2008 to 2011, and less than 
70% had their feet examined by a doctor. In spite of the 
mentioned improvements, KORA and DIAB-CORE data 
also indicate a suboptimal management of blood sugar 
levels and of the cardiovascular risk factors of high blood 
pressure and high LDL cholesterol levels in persons with 
type 2 diabetes [32, 33]. Moreover, DMP data from the North 
Rhine region show that only 51% of type 2 diabetes patients 
with severe foot ulcers also receive treatment from an insti-
tution specialized in treating the feet of diabetics, although 
the agreed target value is at least 75% [40]. In addition, for 
certain aspects the development over time has stagnated 
or begun to reverse. In this study, an increase in the pro-
portion of persons with type 2 diabetes who had their feet 
examined by a doctor and took statins was limited to the 
low education group. With regard to the physical dimen-
sion of quality of life, however, improvements were only 
seen in the high education group. Irrespective of the edu-
data [14]. Moreover, further sources providing additional 
data also indicate improvements in a row of aspects of 
care. Regional KORA (Cooperative Health Research in the 
Region of Augsburg) study data, for example, show an 
increase in the proportion of persons with type 2 diabetes 
who achieve their treatment goal for HbA1c, blood pressure 
and LDL cholesterol as well as a decline in the 10-year risk 
for coronary heart diseases [32]. Current data from studies 
by the DIAB-CORE (Diabetes-Collaborative Research of 
Epidemiologic Studies) consortium indicate an increase in 
awareness, treatment and control of hypertension of people 
both with and without type 2 diabetes [33]. An earlier anal-
ysis of DIAB-CORE data showed that educational level had 
no influence on the presence of a high blood pressure or 
lipid metabolism disorders in persons with type 2 diabetes 
[34]. Furthermore, data from the Disease Management Pro-
gram (DMP) from the North Rhine region reflect an 
increase in type 2 diabetes patients who achieve their blood 
pressure quality targets and have taken part in the recom-
mended diabetes course as well as a stably high proportion 
of patients with an HbA1c value <8.5%. In 2017, ten out of 
14 quantitatively assessable and contractually defined DMP 
quality targets were achieved [35]. Moreover, data from a 
regional stroke registry show that while the stroke rate has 
remained nearly constant for people without diabetes, it 
has decreased for people with diabetes [36]. National data 
from hospital statistics (DRG statistic) show a decrease in 
lower limb amputations (major amputations) in hospi-
talised diabetes patients [37]. Jointly, these positive trends 
could indicate improved outpatient care or better self-mon-
itoring of diabetes. These positive developments may also 
stem from the introduction of modules to the national 
The prevalences of known 
and unknown diabetes and 
the 5-year risk of diabetes are 
considerably higher in the 
low education group than  
in the medium or high 
education group.
Journal of Health Monitoring
Journal of Health Monitoring 2019 4(2)
Social inequality and diabetes mellitus – developments over time among the adult population in Germany
22
FOCUS
points to a less strict tertiary preventive medication ther-
apy of female compared to male diabetes patients. A pos-
sible explanation currently under discussion is the higher 
frequency of the unintended side-effects statins have on 
women than on men [49]. A further possibility is that dia-
betes is underrated as a cardiovascular risk factor in women. 
It has been shown that the cardio-protective effect in 
women compared to men is significantly reduced by the 
presence of a diabetes, in particular with regard to lipid 
metabolism disorders, central obesity and the risk for a 
heart attack [50-53]. Because cardiovascular diseases in 
men develop on average around ten years earlier compared 
to women [50, 51], it is plausible that the proportion of peo-
ple with cardiovascular comorbidities, including among 
diabetes patients, is overall considerably higher for men 
than for women, as is shown, for example, in regional reg-
istry and DMP data for the North Rhine region [36, 54, 55].
This article presents selected indicators related to dia-
betes risk, prevalence and quality of care, which will be 
continuously presented in the context of the national dia-
betes surveillance based on RKI survey data. The strengths 
of this data resource lie in the possibilities to combine 
interview data with measurement and laboratory data as 
well as with subjective perceptions, and thereby compare 
population groups stratified by gender, age or education. 
For the interpretation of stratified results in this article, it 
is important to remember that this is a descriptive analy-
sis. Extended complex analyses would be useful to analyse 
the effects of explanatory factors, such as potential age dif-
ferences between education groups and possible cohort 
effects [56], on the observed results. Furthermore, the 
assessment of social inequality in this article is based exclu-
cation level, persons with type 2 diabetes generally saw a 
slight deterioration in the mental dimensions of quality of 
life. Interestingly, an education gradient for the physical 
dimension of quality of life, with better values achieved by 
the high education group, was also observed for the 30- to 
49-year-old general population based on socioeconomic 
panel (SOEP) data. This was not, however, observed for 
the mental dimension [41]. For first-time renal replacement 
therapy, no decline was observed either in the diabetic or 
non-diabetic population based on data of a regional dialy-
sis centre [42]. Further, North Rhine DMP data indicate a 
decline in the proportion of type 2 diabetes patients who 
have had their kidney function tested during the last twelve 
months [35]. According to epidemiological studies, the inci-
dence rates of complications such as heart attack, stroke, 
lower limb amputations, loss of sight and renal insuffi-
ciency remains two to eight times higher for people with 
diabetes than for those without diabetes, despite improve-
ments observed in some of these complications [43].
Moreover, our results and further studies highlight that 
in addition to educational differences, gender differences 
also persist with regard to prevalence, risk and care of dia-
betes. Men, for example, show a higher prevalence of 
unknown diabetes compared to women [12, 44] as well as 
a higher risk of type 2 diabetes [45-47]. Regarding treatment, 
the results of this study show that for women with known 
diabetes the proportions of those who achieve the non-
HDL cholesterol treatment goal or take statins are lower 
than that of men. Extended analyses based on RKI survey 
data reflect that gender differences in statin use are no 
longer significant once a cardiovascular disease is diag-
nosed in addition to diabetes [21, 48]. This observation 
There is no evident shift of 
the education gradient in the 
prevalence of known and 
unknown diabetes over time.
For the 5-year risk of 
diabetes, there are indica-
tions of a further divergence 
in the educational gap, which 
can be attributed to a clear 
reduction of this risk in the 
high education group.
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ing new available data sources or updating of guideline 
recommendations) as well as a regular and structured pro-
vision of results [61] to promote the planning and evalua-
tion of measures aiming at reducing diabetes risk and sup-
porting early detection and optimal treatment of diabetes. 
It will thereby remain relevant to consider socioeconomic 
factors to assess the need, orientation and prevention 
potential of target group- or settings-focused measures.
Corresponding author
Dr Christin Heidemann
Robert Koch Institute 




Please cite this publication as
Heidemann C, Du Y, Baumert J, Paprott R, Lampert T et al. (2019) 
Social inequality and diabetes mellitus – developments over time 
among the adult population in Germany. 
Journal of Health Monitoring 4(2): 11-28. 
DOI 10.25646/5986
The German version of the article is available at: 
www.rki.de/journalhealthmonitoring
Data protection and ethics
The studies GNHIES98 and DEGS1 are subject to strict 
compliance with the data protection regulations of the Fed-
eral Data Protection Act and have been approved by the 
Federal Commissioner for Data Protection and Freedom 
of Information in Germany. Charité – Universitätsmedizin 
Berlin’s ethics committee assessed the ethics of the study 
sively on the operationalisation of individual school edu-
cation and professional training. Other established oper-
ationalisations to describe social inequality of people or 
households are based on professional status, income or 
multi-dimensional indices composed of the three dimen-
sions of education, occupational status and income [56, 
57]. Moreover, to operationalise social inequality, regional 
level measures such as the unemployment rate, poverty 
risk rate or again multi-dimensional indices are often 
applied, for example, when individual level data are not 
available [58, 59]. 
The limitations connected to the applied RKI survey data 
are that certain groups of people – in particular seriously 
ill persons, nursing home residents, persons with a migra-
tion background, and (in examination surveys) persons 
aged 80 years and over – have so far not been representa-
tively included and that the limited number of feasible sur-
vey participants usually does not allow multi-layered strat-
ifications. For this study, for example, the number of cases 
following stratification by education group and, additionally, 
gender were sometimes too small to evidence statistical 
significance, despite the potential existence of differences 
between groups.
Looking to the future, a stable data synthesis of key dia-
betes indicators by merging of RKI survey data with avail-
able secondary data, which are discussed in the article Sec-
ondary data in diabetes surveillance – co-operation projects 
and definition of references on the documented prevalence 
of diabetes in this issue [60], should be ensured in the con-
text of the national diabetes surveillance system [6]. The 
planned next steps include a regular review of the set of 
indicators [7] for required adaptions (for example, regard-
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Overall, the quality of 
diabetes care has improved 
over time.
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